FARMACIA Y SALUD
Doktorandenschule
Vita-Salute San Raffaele University
Milán, ItaliaPublikationen in Zusammenarbeit mit Forschern von Vita-Salute San Raffaele University (1)
2024
-
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study
United European Gastroenterology Journal